Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Endothelium-Derived Hyperpolarizing Factor in Humans
NCT00166166Phase 2Terminated
- Sponsor
- Emory University
- Start
- Jul 2002
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of tetraethylammonium, NG-monomethyl-L-arginine, bradykinin, sodium nitroprusside, acetylcholine in hyperlipidemia, sponsored by Emory University. Started Jul 2002; status: terminated.
02
Drugs
tetraethylammoniumNG-monomethyl-L-argininebradykininsodium nitroprussideacetylcholine
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00166166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166166.